Prof. Lim is the Executive Director of the Department of Clinical Research and Advancement, Portfolio of Deputy Vice Chancellor (Research & Innovation), Universiti Malaya, Kuala Lumpur, Malaysia. She is a Senior Consultant Endocrinologist and former Head of the Diabetes Care Unit, Universiti Malaya (2022-2025). She is also the Clinical Professor (Honorary) at the Hong Kong Institute of Diabetes and Obesity (HKIDO), the Chinese University of Hong Kong (CUHK), and the Baker Heart and Diabetes Institute, Melbourne, Australia. As a clinician-scientist, Prof. Lim’s major areas of interest are cardiometabolic medicine (epidemiology, molecular, and implementation science). 

Prof. Lim sits on the Scientific Work Groups of the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) Precision Medicine in Diabetes Initiative and the World Health Organization (WHO) Global Diabetes Compact. Since 2025, she has served as a Co-Chair of The Lancet Commission on Precision Health. She has published more than 160 high-impact peer-reviewed articles, including in The Lancet, Nature, and Diabetes Care.

Prof. Lim has received several awards, including the 2025 Malaysia Scopus Research Star Award – Women in Research Excellence (STEM) Category, Universiti Malaya’s Top Cited Researcher 2024, World’s Top 2% Scientists by Stanford University for 5 consecutive years (2022-2026), and the European Foundation for the Study of Diabetes (EFSD) Albert Renold Fellowship, tenable at the University of Oxford, UK.

She is an Associate Editor of Diabetologia (top 6%) and an Editorial Board Member of several Tier 1 journals (BMC Medicine, Diabetes & Metabolism Journal, and Diabetes/Metabolism Research & Reviews). She is also the Vice President of Diabetes Malaysia (a country affiliate of the International Diabetes Federation) and a Council Member of the Malaysian Endocrine and Metabolic Society.